X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6102) 6102
Book Chapter (122) 122
Dissertation (12) 12
Book / eBook (10) 10
Magazine Article (8) 8
Publication (5) 5
Conference Proceeding (4) 4
Newsletter (3) 3
Newspaper Article (3) 3
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4399) 4399
humans (4129) 4129
life sciences & biomedicine (3932) 3932
animals (2802) 2802
prodrugs - therapeutic use (2208) 2208
pharmacology & pharmacy (2060) 2060
male (1553) 1553
prodrugs (1553) 1553
female (1403) 1403
mice (1230) 1230
prodrugs - pharmacology (1226) 1226
prodrugs - pharmacokinetics (1085) 1085
prodrugs - chemistry (1071) 1071
prodrugs - administration & dosage (966) 966
oncology (810) 810
prodrug (808) 808
prodrugs - metabolism (790) 790
chemistry (786) 786
physical sciences (770) 770
cancer (758) 758
cell line, tumor (689) 689
rats (667) 667
drug delivery systems (631) 631
adult (614) 614
middle aged (609) 609
drugs (594) 594
chemistry, multidisciplinary (576) 576
antineoplastic agents - therapeutic use (563) 563
prodrugs - chemical synthesis (522) 522
biochemistry & molecular biology (512) 512
neoplasms - drug therapy (502) 502
chemistry, medicinal (474) 474
administration, oral (464) 464
aged (457) 457
prodrugs - adverse effects (412) 412
analysis (391) 391
dose-response relationship, drug (387) 387
treatment outcome (381) 381
enzymes (374) 374
antineoplastic agents - pharmacology (372) 372
tumors (372) 372
research (370) 370
chemotherapy (369) 369
drug design (361) 361
mice, nude (361) 361
care and treatment (354) 354
pharmacology/toxicology (354) 354
pharmacokinetics (351) 351
health aspects (341) 341
medicine, research & experimental (341) 341
research & experimental medicine (341) 341
drug therapy (322) 322
molecular structure (306) 306
science & technology - other topics (301) 301
chemical compounds (298) 298
genetic therapy - methods (296) 296
drug delivery (287) 287
hydrolysis (285) 285
antineoplastic agents - chemistry (278) 278
rats, sprague-dawley (276) 276
tumor cells, cultured (274) 274
solubility (260) 260
biotechnology & applied microbiology (258) 258
mice, inbred balb c (258) 258
structure-activity relationship (257) 257
gene therapy (255) 255
pharmacology (251) 251
cell survival - drug effects (250) 250
technology (241) 241
xenograft model antitumor assays (241) 241
antineoplastic agents - administration & dosage (238) 238
antiviral agents - therapeutic use (238) 238
biomedicine (232) 232
clinical trials as topic (232) 232
cytotoxicity (229) 229
abridged index medicus (226) 226
pharmacy (219) 219
drug stability (218) 218
disease models, animal (217) 217
toxicity (216) 216
deoxycytidine - analogs & derivatives (213) 213
nanoparticles (213) 213
biological availability (212) 212
materials science (210) 210
vehicles (208) 208
time factors (205) 205
double-blind method (200) 200
biochemistry, general (197) 197
genetic therapy (194) 194
medicine & public health (189) 189
neoplasms - therapy (189) 189
adolescent (188) 188
chromatography, high pressure liquid (185) 185
kinetics (184) 184
biotransformation (180) 180
cancer therapies (176) 176
tissue distribution (176) 176
genetics & heredity (174) 174
apoptosis (173) 173
dosage and administration (173) 173
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6110) 6110
German (85) 85
Japanese (82) 82
French (44) 44
Russian (14) 14
Spanish (13) 13
Italian (7) 7
Chinese (6) 6
Czech (3) 3
Polish (3) 3
Swedish (3) 3
Dutch (2) 2
Portuguese (2) 2
Danish (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2007, Volume 357, Issue 20, pp. 2001 - 2015
Journal Article
Nature reviews. Cancer, ISSN 1474-1768, 11/2001, Volume 1, Issue 2, pp. 118 - 129
...Antibodies are finally realizing their potential as anticancer therapeutics: since 1995, five antibodies have been approved for the treatment of cancer (Table... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Prodrugs - administration & dosage | Recombinant Fusion Proteins - immunology | Antibodies, Neoplasm - therapeutic use | Immunotherapy - methods | Humans | Recombinant Fusion Proteins - therapeutic use | Neoplasm Proteins - immunology | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Drug Delivery Systems | Neoplasm, Residual | Antibodies, Monoclonal, Humanized | Clinical Trials, Phase III as Topic | Neoplasms - therapy | Protein Engineering | Antibodies - immunology | Immunoconjugates - therapeutic use | Neoplasms - radiotherapy | Neovascularization, Pathologic - immunology | Antibodies, Monoclonal - immunology | Neovascularization, Pathologic - therapy | Antibodies - therapeutic use | Cytokines - therapeutic use | Antibodies, Neoplasm - immunology | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity | Antigens, Neoplasm - immunology | Radioimmunotherapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Cytokines - administration & dosage | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Antibodies, Bispecific - therapeutic use | Animals | Immunotoxins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Immunization, Passive | Mice | Liposomes | Neoplasms - pathology | Trastuzumab | Clinical Trials, Phase II as Topic | Viral antibodies | Usage | Care and treatment | Antibodies | Research | Health aspects | Methods | Cancer | Herceptin | Rituxan | vascular endothelial growth factor | Avastin | Index Medicus
Journal Article